Skip to main content

News and Events

New business mentoring scheme to help early career researchers

Warwick Ventures is piloting a new mentoring scheme to match experienced business professionals with early career researchers to help coach the researchers and encourage them in viewing their ideas through a commercial lens.

Tue 16 January 2018, 09:03 | Tags: ICURe

VirionHealth Receives up to $4.2m from DARPA

VirionHealth Ltd, a new biotechnology company developing novel therapeutics for respiratory viral infections, today announced that it has won non-dilutive funding worth up to $4.2 million from the US Defense Advanced Research Projects Agency (DARPA).

Tue 09 January 2018, 10:47 | Tags: Warwick Ventures

Warwick spin-out Medherant completes £3.8 million funding round

Medherant, a spin-out company from the University of Warwick developing an innovative transdermal drug delivery patch technology, has raised £3.8 million in its latest funding round.

Wed 20 December 2017, 08:41 | Tags: Warwick Ventures, Chemistry

Spin-out Medherant wins Excellence in Science and Technology Award

Warwick spin-out Medherant Ltd has won the Excellence in Science and Technology Award at the Coventry Telegraph Business Awards 2017. The regional business award recognises the team’s rapid progress and innovation in the development of next-generation transdermal drug delivery patches. Read more about Medherant here.

Thu 23 November 2017, 14:29

Base4 Innovation Ltd. closes £5 million ($6.5 million) funding round

Founded in 2007 with support from Warwick Ventures and the University of Warwick, Base4 has just closed a £5 million funding round, the company's largest to date. The funds will be used to expand the current team and increase lab space, facilitating the continued fast-paced development and automation of its technology.

Wed 22 November 2017, 15:08 | Tags: Warwick Ventures, Life Sciences and Biotechnology

VirionHealth Raises Series A Funding from Abingworth

virionhealth_signing.jpgVirionHealth Ltd, a new biotechnology company developing novel therapeutics for respiratory viral infections, today announced that it has raised up to £13 million in Series A funding from Abingworth, the international investment group dedicated to life sciences.

VirionHealth is a University of Warwick spinout company, set up with the support of Warwick Ventures, in 2017. Dr Laura Lane, Business Development Manager at Warwick Ventures, worked closely with Professors Nigel Dimmock and Andrew Easton to build a commercial team and secure the largest single investment into a Warwick spinout.

Warwick Ventures also helped secure translational funding from the Wellcome Trust, maintained the patents and developed the business plan that led to the investment by Abingworth.

Thu 12 October 2017, 13:27 | Tags: Warwick Ventures, Life Sciences and Biotechnology

Interface Polymers announces new investment

The University of Warwick is celebrating the continued success of its spinout Interface Polymers, following the company’s most recent investment of £2m led by private capital investment group 24Haymarket.

Fri 29 September 2017, 14:50 | Tags: Warwick Ventures, Chemistry

Warwick Audio Technologies announces new investment

Warwick spinout Warwick Audio Technologies has secured £3.1m in new funding, including £1.9m from Mercia Technologies PLC.

The funds raised will be used by the company to continue development and marketing of its Sonoma Model One headphone system.

Click here to view the press release from Mercia Technologies PLC.

Wed 20 September 2017, 09:51 | Tags: Engineering

University spinouts shortlisted for biosciences award

Two Warwick spinout companies have been shortlisted in the 2017 OBN Awards.

Mon 11 September 2017, 12:23 | Tags: Warwick Ventures

Could your innovation change the world?

The Royal Academy of Engineering is looking for applicants to join its Enterprise Fellowship Programme.

Open to all entrepreneurial academics and recent graduates, the programme offers up to £60,000 to help you to bring your innovative technology to market


Fri 18 August 2017, 07:49

Older news